Li Luxi, Zhang Qiongyue, Zhang Peng
Department of Ophthalmology, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, CHN.
Cureus. 2024 Dec 3;16(12):e75056. doi: 10.7759/cureus.75056. eCollection 2024 Dec.
Choroidal nevus is the most common intraocular tumor, and most cases are benign and have no symptoms. However, choroidal nevus carries a low risk for transformation into melanoma, which is a highly aggressive and deadly cancer. In this case report, we present a male patient with blurred vision in his left eye for six months. Multimodal fundus imaging reported a large pigmented gray-brown choroidal lesion adjacent to the optic disc in his left eye, along with intraretinal and subretinal fluid (SRF) accumulation involving the macula and fluorescein leakage. Choroidal nevus was then diagnosed, and bevacizumab was given by intravitreal injection. After one month of bevacizumab treatment, spectral-domain optical coherence tomography showed a decrease in SRF. After four months of bevacizumab treatment, the patient suffered from more SRF and an elevated lesion in his left eye. During subsequent follow-up, the lesion continued to increase in size. Given the possibility of a malignant transformation of choroidal nevus into melanoma, transpupillary thermotherapy (TTT) was performed. The choroidal melanoma appeared to be necrotic at 10 months post-TTT. The patient's left eye was enucleated due to neovascular glaucoma 17 months post-TTT. Histopathologic examination showed diffuse infiltration of melanoma cells in the retina, choroid and optic nerve, and cell growth on the surface of the optic nerve papilla. Multiple treatment modalities, including external beam radiotherapy and systemic chemotherapy, were applied, but the patient eventually died due to metastasis. Patients with choroidal nevus should be managed with multimodal fundus imaging and be closely followed up due to the risk of transformation into a malignant melanoma. For cases with clinical and imaging features of malignant transformation, early intervention and long-term follow-up are required to achieve local disease control and vision preservation.
脉络膜痣是最常见的眼内肿瘤,大多数病例为良性且无症状。然而,脉络膜痣有低风险转变为黑色素瘤,黑色素瘤是一种极具侵袭性和致命性的癌症。在本病例报告中,我们介绍了一名左眼视力模糊6个月的男性患者。多模式眼底成像报告显示其左眼视盘附近有一个大的色素性灰棕色脉络膜病变,伴有累及黄斑的视网膜内和视网膜下液(SRF)积聚以及荧光素渗漏。随后诊断为脉络膜痣,并通过玻璃体腔内注射给予贝伐单抗。贝伐单抗治疗1个月后,频域光学相干断层扫描显示SRF减少。贝伐单抗治疗4个月后,患者左眼SRF增多且病变增大。在随后的随访中,病变持续增大。鉴于脉络膜痣有恶变转化为黑色素瘤的可能性,遂进行了经瞳孔温热疗法(TTT)。TTT治疗10个月后脉络膜黑色素瘤似乎出现坏死。TTT治疗17个月后,患者因新生血管性青光眼而摘除了左眼。组织病理学检查显示黑色素瘤细胞在视网膜、脉络膜和视神经中弥漫浸润,且在视神经乳头表面有细胞生长。应用了包括外照射放疗和全身化疗在内的多种治疗方式,但患者最终因转移而死亡。脉络膜痣患者应采用多模式眼底成像进行管理,并因其有恶变转化为恶性黑色素瘤的风险而密切随访。对于具有恶变临床和影像学特征的病例,需要早期干预和长期随访以实现局部疾病控制和视力保留。